SCHEMBL2807684

SCHEMBL2807684

[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL174801 0.79
SCHEMBL31135791 0.74
SCHEMBL31135792 0.74
Hexadecane SCHEMBL12473013 0.74
Decane SCHEMBL29555442 0.74
Pentane SCHEMBL7259903 0.72
SCHEMBL29733483 0.69
SCHEMBL29733482 0.69
Nonane SCHEMBL29844267 0.69
Tridecane SCHEMBL29733480 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066290-A1 DHODH INHIBITORS CONTAINING A CARBOXYLIC ACID BIOISOSTERE IMMUNIC AG (DE) 2025-02-27 US disclosed
WO-2018039521-A1 DEUTERATED CENICRIVIROC CONCERT PHARMACEUTICALS, INC. (US) 2018-03-01 WO disclosed
US-20100240137-A1 DERIVATIZATION-ENHANCED ANALYSIS OF AMINO ACIDS AND PEPTIDES PURDUE RESEARCH FOUNDATION (US) 2010-09-23 US disclosed
EP-2016054-A2 DERIVATIZATION-ENHANCED ANALYSIS OF AMINO ACIDS AND PEPTIDES Purdue Research Foundation (US) 2009-01-21 EP disclosed
US-20080050827-A1 Derivatization-enhanced analysis of amino acids and peptides NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-02-28 US disclosed
WO-2007117665-A2 DERIVATIZATION-ENHANCED ANALYSIS OF AMINO ACIDS AND PEPTIDES PURDUE RESEARCH FOUNDATION (US) 2007-10-18 WO disclosed